title: The Watchman saga--closure at last?
authors.affiliation: From Harvard Medical School (D.B.K., A.S.K.), the Cardiovascular Institute, Beth Israel Deaconess Medical Center (D.B.K.), the Hebrew SeniorLife Institute for Aging Research (D.B.K.), and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital (A.S.K.) - all in Boston.
authors.forename: Daniel B
authors.initials: DB
authors.lastname: Kramer
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
mesh_terms: D020517:Atrial Appendage; D001281:Atrial Fibrillation / Q000628:therapy*; D018795:Device Approval / Q000331:legislation & jurisprudence; D005062:European Union; D033161:Government Regulation; D006801:Humans; D011358:Product Surveillance, Postmarketing; D019736:Prostheses and Implants; D013923:Thromboembolism / Q000517:prevention & control*; D014481:United States; D014486:United States Food and Drug Administration